GlobalData on MSN2d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...
AstraZeneca says experimental obesity pill safe in early-stage trial
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
AstraZeneca’s Tezspire Shows Promise in Phase III Trial
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
FierceBiotech6d
AstraZeneca talks up potential for obesity combo treatments, insists it's 'playing to win' in crowded field
AstraZeneca is gearing up for a mid-stage trial of AZD6234 in combination with its weekly GLP-1/glucagon candidate AZD9550. This once-weekly combo treatment should provide a “triple mechanism ...
Yahoo Finance1mon
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
UK-based pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial of Airsupra (albuterol/budesonide) in patients with intermittent or mild persistent asthma met its primary ...
Khaleej Times6d
New obesity pill is safe and tolerable in early stage trial: AstraZeneca
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial. The Phase I trial, which had 72 participants ...
GMA Network6d
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...